Nisha R Acharya

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Corticosteroid-sparing therapy: practice patterns among uveitis specialists
    Elizabeth Esterberg
    F I Proctor Foundation, University of California San Francisco, Room S309, 513 Parnassus Avenue, San Francisco, CA, 94143 0412, USA
    J Ophthalmic Inflamm Infect 2:21-8. 2012
  2. ncbi request reprint Mooren''s ulcer following extracapsular cataract extraction
    N R Acharya
    The Francis I Proctor Foundation, University of California, San Francisco USA
    Eur J Ophthalmol 18:351-5. 2008
  3. doi request reprint Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, California 94143 0412, USA
    Retina 31:1871-6. 2011
  4. doi request reprint Ranibizumab for refractory uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143, USA
    Am J Ophthalmol 148:303-309.e2. 2009
  5. pmc Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California, San Francisco, CA, USA
    Ophthalmic Epidemiol 20:155-8. 2013
  6. pmc Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis
    Kathryn J Ray
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA Ophthalmol 131:310-3. 2013
  7. doi request reprint Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California San Francisco, 513 Parnassus Avenue, Room S309, San Francisco, CA 94117, USA
    Invest Ophthalmol Vis Sci 54:1522-6. 2013
  8. doi request reprint Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco2Department of Ophthalmology, University of California, San Francisco
    JAMA Ophthalmol 131:1405-12. 2013
  9. pmc Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study
    Gelareh Homayounfar
    F I Proctor Foundation, University of California, San Francisco, California
    Am J Ophthalmol 156:752-8. 2013
  10. pmc Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial
    Craig W See
    FI Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    Ophthalmic Epidemiol 19:407-13. 2012

Research Grants

Collaborators

  • Thomas M Lietman
  • Stephen D McLeod
  • Kathryn J Ray
  • Travis C Porco
  • Prajna Lalitha
  • Michael E Zegans
  • Todd P Margolis
  • Jeremy D Keenan
  • Elmer Y Tu
  • Elisabeth J Cohen
  • Bennie H Jeng
  • Wantanee Sittivarakul
  • Catherine E Oldenburg
  • Muthiah Srinivasan
  • Durga S Borkar
  • Jeena Mascarenhas
  • Elizabeth Esterberg
  • Revathi Rajaraman
  • Aileen Sy
  • Ying Qian
  • Allison R Loh
  • Meenakshi Ravindran
  • N Venkatesh Prajna
  • John P Whitcher
  • Agnieszka Nagpal
  • Aleli C Vinoya
  • Aileen Uchida
  • John V Parker
  • Vivien M Tham
  • Natalie Nardone
  • Gelareh Homayounfar
  • Catherine Q Sun
  • Charles C Lin
  • Joseph N Martel
  • Cyril Dalmon
  • Craig W See
  • Mark J Mannis
  • Robert E Fintelmann
  • Bruce D Gaynor
  • Yousuf M Khalifa
  • Lalitha Prajna
  • Phoebe Lin
  • Yousuf Khalifa
  • Aiyin Chen
  • Palanisamy Manikandan
  • Tiruvengada Krishnan
  • Wayne T A Enanoria
  • Avanti A Ghanekar
  • David V Glidden
  • Anita Raghavan
  • Suzanne M J Fleiszig
  • Connie Tam
  • Kieran S O'Brien
  • Chelsia Leong
  • M Jayahar Bharathi
  • Wing Y Li
  • Tanya Glaser
  • Elizabeth J Esterberg
  • Matilda F Chan
  • Somu Saravanan
  • Mano Ranjan Das
  • David Glidden
  • J Arun Kumar
  • Tanya S Glaser
  • Vicky Cevallos
  • Eliza N Hoskins
  • M Rami Bailony
  • Rajendran Mahalakshmi
  • Julie F Leigh

Detail Information

Publications28

  1. pmc Corticosteroid-sparing therapy: practice patterns among uveitis specialists
    Elizabeth Esterberg
    F I Proctor Foundation, University of California San Francisco, Room S309, 513 Parnassus Avenue, San Francisco, CA, 94143 0412, USA
    J Ophthalmic Inflamm Infect 2:21-8. 2012
    ..This study aims to determine uveitis specialists' practice patterns, preferences, and perceptions of corticosteroid-sparing therapies for the initial treatment of chronic noninfectious uveitis...
  2. ncbi request reprint Mooren''s ulcer following extracapsular cataract extraction
    N R Acharya
    The Francis I Proctor Foundation, University of California, San Francisco USA
    Eur J Ophthalmol 18:351-5. 2008
    ..Prior cataract surgery is a recognized risk factor for the development of Mooren''s ulcer, but the demographic and clinical features of a large cohort of such patients have not been described...
  3. doi request reprint Bilateral effect of unilateral ranibizumab in patients with uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, California 94143 0412, USA
    Retina 31:1871-6. 2011
    ..To describe an observed therapeutic effect of ranibizumab in untreated contralateral eyes of patients with bilateral uveitis-related cystoid macular edema...
  4. doi request reprint Ranibizumab for refractory uveitis-related macular edema
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143, USA
    Am J Ophthalmol 148:303-309.e2. 2009
    ....
  5. pmc Emerging moxifloxacin resistance in Pseudomonas aeruginosa keratitis isolates in South India
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California, San Francisco, CA, USA
    Ophthalmic Epidemiol 20:155-8. 2013
    ..To describe temporal trends in Pseudomonas aeruginosa resistance to moxifloxacin in keratitis isolates from South India...
  6. pmc Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis
    Kathryn J Ray
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    JAMA Ophthalmol 131:310-3. 2013
    ..To analyze the relationship between fluoroquinolone use at presentation and minimum inhibitory concentration in bacterial keratitis...
  7. doi request reprint Moxifloxacin susceptibility mediates the relationship between causative organism and clinical outcome in bacterial keratitis
    Catherine E Oldenburg
    Francis I Proctor Foundation, University of California San Francisco, 513 Parnassus Avenue, Room S309, San Francisco, CA 94117, USA
    Invest Ophthalmol Vis Sci 54:1522-6. 2013
    ..In this report, we analyze the role of moxifloxacin susceptibility in the relationship between causative organisms and clinical outcome in bacteria keratitis...
  8. doi request reprint Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study
    Nisha R Acharya
    F I Proctor Foundation, University of California, San Francisco2Department of Ophthalmology, University of California, San Francisco
    JAMA Ophthalmol 131:1405-12. 2013
    ..Uveitis is responsible for a significant proportion of legal blindness in the United States. Currently, there are few population-based reports characterizing the epidemiology of uveitis...
  9. pmc Incidence of scleritis and episcleritis: results from the Pacific Ocular Inflammation Study
    Gelareh Homayounfar
    F I Proctor Foundation, University of California, San Francisco, California
    Am J Ophthalmol 156:752-8. 2013
    ..To ascertain the incidence of scleritis and episcleritis in a Hawaiian population and describe variations by age, sex, and race...
  10. pmc Prior elicitation and Bayesian analysis of the Steroids for Corneal Ulcers Trial
    Craig W See
    FI Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    Ophthalmic Epidemiol 19:407-13. 2012
    ..To elicit expert opinion on the use of adjunctive corticosteroid therapy in bacterial corneal ulcers. To perform a Bayesian analysis of the Steroids for Corneal Ulcers Trial (SCUT), using expert opinion as a prior probability...
  11. pmc Association between cytotoxic and invasive Pseudomonas aeruginosa and clinical outcomes in bacterial keratitis
    Durga S Borkar
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    JAMA Ophthalmol 131:147-53. 2013
    ..To determine whether cytotoxic and invasive Pseudomonas aeruginosa strains differentially influence clinical presentation, outcomes, or therapeutic response in bacterial keratitis...
  12. doi request reprint Seasonal trends of microbial keratitis in South India
    Charles C Lin
    Department of Ophthalmology, University of California San Francisco, San Francisco, CA 94143 0412, USA
    Cornea 31:1123-7. 2012
    ..This study analyzes seasonal trends in the incidence of fungal and bacterial keratitis at the Aravind Eye Hospital in southeast India...
  13. pmc Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I
    Catherine Q Sun
    Francis I Proctor Foundation, University of California, San Francisco, San Francisco, California, USA
    Invest Ophthalmol Vis Sci 54:4167-73. 2013
    ..To perform a Bayesian analysis of the Mycotic Ulcer Treatment Trial I (MUTT I) using expert opinion as a prior belief...
  14. pmc Practice patterns and opinions in the management of recurrent or chronic herpes zoster ophthalmicus
    Aileen Sy
    Department of Ophthalmology, F I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA
    Cornea 31:786-90. 2012
    ..The objective of this study was to determine current practices and opinions among cornea specialists for treating and preventing recurrences of herpes zoster ophthalmicus (HZO)...
  15. pmc Pseudomonas aeruginosa keratitis: outcomes and response to corticosteroid treatment
    Aileen Sy
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA
    Invest Ophthalmol Vis Sci 53:267-72. 2012
    ..To compare the clinical course and effect of adjunctive corticosteroid therapy in Pseudomonas aeruginosa with those of all other strains of bacterial keratitis...
  16. pmc The clinical differentiation of bacterial and fungal keratitis: a photographic survey
    Cyril Dalmon
    F I Proctor Foundation and Department of Ophthalmology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143, USA
    Invest Ophthalmol Vis Sci 53:1787-91. 2012
    ..The purpose of this study was to determine whether clinical signs of infectious keratitis can be used to identify the causative organism...
  17. pmc Incidence of herpes zoster ophthalmicus: results from the Pacific Ocular Inflammation Study
    Durga S Borkar
    F I Proctor Foundation, University of California, San Francisco, San Francisco, California, USA
    Ophthalmology 120:451-6. 2013
    ..To provide a population-based estimate of the incidence of herpes zoster ophthalmicus (HZO) with comparisons across racial, sex, and age groups, as well as to estimate the frequency of postherpetic neuralgia (PHN)...
  18. doi request reprint Infliximab and adalimumab for uveitis
    Joseph N Martel
    Department of Ophthalmology, University of California, San Francisco, California 94143 0412, USA
    Ocul Immunol Inflamm 20:18-26. 2012
    ..To describe the corticosteroid-sparing success in controlling chronic uveitis in patients treated with TNF╬▒ inhibitors...
  19. pmc Depression and visual functioning in patients with ocular inflammatory disease
    Ying Qian
    Francis I Proctor Foundation, University of California, San Francisco, CA 94143 0412, USA
    Am J Ophthalmol 153:370-378.e2. 2012
    ..To characterize the level of depression in patients with ocular inflammatory disease and to determine predictors of depression in this population...
  20. pmc Practice patterns and opinions in the treatment of acanthamoeba keratitis
    Catherine E Oldenburg
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0944, USA
    Cornea 30:1363-8. 2011
    ..Management of acanthamoeba keratitis remains challenging for ophthalmologists. We conducted a survey of members of The Cornea Society to elicit expert opinions on the diagnosis and treatment of acanthamoeba keratitis...
  21. pmc Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures
    Robert E Fintelmann
    Francis I Proctor Foundation for Research in Ophthalmology, University of California San Francisco, 513 Parnassus Avenue, San Francisco, CA 94143 0412, USA
    Arch Ophthalmol 129:399-402. 2011
    ..To determine whether recent use of topical fluoroquinolones is a risk factor for in vitro fluoroquinolone resistance in Staphylococcus aureus ocular isolates...
  22. doi request reprint Fluocinolone acetonide intravitreal implants in Vogt-Koyanagi-Harada disease
    Yousuf Khalifa
    F I Proctor Foundation, University of California, San Francisco, California 94143 0412, USA
    Ocul Immunol Inflamm 17:431-3. 2009
    ..To describe the use of fluocinolone acetonide implants (Retisert) in Vogt-Koyanagi-Harada disease (VKH)...
  23. pmc Incidence rates and risk factors for ocular complications and vision loss in HLA-B27-associated uveitis
    Allison R Loh
    F I Proctor Foundation, University of California, San Francisco, San Francisco, CA 94143 0412, USA
    Am J Ophthalmol 150:534-542.e2. 2010
    ..To calculate the incidence rates of ocular complications and vision loss in HLA-B27-associated uveitis and to explore the effect of chronic inflammation on clinical outcomes...
  24. doi request reprint Treatment of pediatric vogt-koyanagi-harada syndrome with infliximab
    Yousuf M Khalifa
    F I Proctor Foundation, University of California at San Francisco, San Francisco, California, USA
    Ocul Immunol Inflamm 18:218-22. 2010
    ..Conclusions: Infliximab as adjunctive therapy in pediatric VKH showed a benefit in reducing systemic corticosteroid exposure in 1 patient, but incomplete timely resolution of inflammation in another patient...
  25. pmc Juvenile idiopathic arthritis-associated uveitis
    Ying Qian
    F I Proctor Foundation, San Francisco, California, USA
    Curr Opin Ophthalmol 21:468-72. 2010
    ..To describe recent evidence from the literature pertaining to juvenile idiopathic arthritis (JIA)-associated uveitis...
  26. pmc Cigarette smoking as a risk factor for uveitis
    Phoebe Lin
    F I Proctor Foundation, University of California, San Francisco, California 94143 0944, USA
    Ophthalmology 117:585-90. 2010
    ..To determine the association between tobacco smoking history and uveitis...
  27. doi request reprint Epidemiology of uveitis in children
    Agnieszka Nagpal
    FI Proctor Foundation University of California, San Francisco 513 Parnassus Ave, S 334 San Francisco, CA 94143, USA
    Int Ophthalmol Clin 48:1-7. 2008
  28. pmc Does in vitro susceptibility predict clinical outcome in bacterial keratitis?
    Aiyin Chen
    F I Proctor Foundation, Department of Ophthalmology, University of California, San Francisco, San Francisco, California 94143, USA
    Am J Ophthalmol 145:409-412. 2008
    ..To determine whether clinical outcomes in bacterial keratitis are associated with antibiotic susceptibility...

Research Grants2

  1. Predicting and Improving Clinical Outcomes for Bacterial Keratitis
    Nisha Acharya; Fiscal Year: 2007
    ..Our goal is to provide data to allow clinicians to risk-stratify patients with bacterial corneal ulcers in an evidence-based manner. ..